• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Home
  • LinkedIn
  • Twitter

  • About Us
    • Overview
    • Executive Committee
    • Board Of Directors
    • Partners
  • Science
    • Overview
    • Approach
    • Technology
      • Our Technology
      • TIM
      • shRNA
      • shARC Platform
    • Scientific Publications
  • Pipeline
  • Newsroom
    • Press Releases
    • Events
    • Media Center
  • Investors
    • Overview
    • Analyst Coverage
    • Corporate Governance
    • Regulated Information
    • Shareholders Information
    • Shareholders Meeting
  • Careers
  • Contact Us

Celyad Oncology to Host Virtual Research & Development Webinar on September 29, 2020

September 22, 2020 By Celyad Oncology

Mont-Saint-Guibert, Belgium – Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced it will host a Research & Development webinar on Tuesday, September 29th at 11:00 a.m. EDT.

The program will provide insights into the company’s novel, non-gene edited allogeneic CAR T candidates CYAD-101 for metastatic colorectal cancer and CYAD-211 for relapsed / refractory multiple myeloma as well as the company’s short hairpin RNA (shRNA) platform and all-in-one vector approach. The featured speaker, Dr. Richard Kim, M.D., Professor of Oncology, Moffitt Cancer Center, will discuss the immuno-oncology and treatment landscapes for metastatic colorectal cancer. Members of Celyad Oncology’s management will highlight recent developments in the company’s pipeline and discuss the future direction for additional next-generation, allogeneic CAR T candidates.

The live webcast of the presentation can be accessed by visiting the “Events” section of the Celyad Oncology website.  Please connect to the webcast several minutes prior to the start of the event to ensure the connection. To register for the live webcast, click here.  After the conclusion of event, a replay of the webcast will also be available on the Celyad Oncology website.  

Download press release(s)
Communiqué de presse
Press Release
Persbericht

Filed Under: Uncategorized

Footer

Celyad Oncology

Celyad Oncology Logo
  • About
  • Science
  • Pipeline
  • Newsroom
  • Investors
  • Contact Us
  • LinkedIn
  • Twitter

Copyright © 2020 All Rights Reserved.

  • Cookie Policy |
  • Privacy Policy |
  • Terms of Use